VERA · US market

Vera Therapeutics, Inc.

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$2.23bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E-5.56×
Latest-quarter run-rate P/E-5.10×
Trailing P/SUnavailable
Latest-quarter run-rate P/SUnavailable

Calculation inputs

Trailing earnings
-US$401.90m
Latest-quarter run-rate earnings
-US$437.89m
Latest fiscal-year earnings
-US$299.62m
Trailing revenue
US$0.00
Latest-quarter run-rate revenue
US$0.00
Latest fiscal-year revenue
Unavailable

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

  • MCGIX · AMG GW&K Small Cap Growth Fund - Class I0.80% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • SSDZX · DWS Small Cap Growth Fund - Class R60.78% weight · Holdings dated 30 June 2026
  • XBI · State Street SPDR S&P Biotech ETF0.77% weight · Holdings dated 21 August 2026
  • QUAZX · AB Small Cap Growth Portfolio Class Z0.44% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • CHCLX · AB Discovery Growth Fund Class A0.41% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • ANOAX · American Century Small Cap Growth Fund A Class0.39% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • NMCAX · Voya MidCap Opportunities Fund Class A0.38% weight · Holdings dated 31 May 2026
  • GSAOX · Goldman Sachs Small Cap Growth Insights Fund Class A0.27% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • CTSOX · Calamos Timpani Small Cap Growth Fund Class R60.24% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • GCSAX · Goldman Sachs Small Cap Equity Insights Fund Class A0.20% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.